Identification of a peripheral blood gene signature predicting aortic valve calcification.


Journal

Physiological genomics
ISSN: 1531-2267
Titre abrégé: Physiol Genomics
Pays: United States
ID NLM: 9815683

Informations de publication

Date de publication:
01 12 2020
Historique:
pubmed: 13 10 2020
medline: 15 9 2021
entrez: 12 10 2020
Statut: ppublish

Résumé

Calcific aortic valve disease (CAVD) is a significant cause of illness and death worldwide. Identification of early predictive markers could help optimize patient management. RNA-sequencing was carried out on human fetal aortic valves at gestational

Identifiants

pubmed: 33044885
doi: 10.1152/physiolgenomics.00034.2020
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

563-574

Auteurs

Donal MacGrogan (D)

Intercellular Signaling in Cardiovascular Development and Disease Laboratory, Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.
Ciber de Enfermedades Cardiovasculares, Instituto de Salud Carlos III, Madrid, Spain.

Beatriz Martínez-Poveda (B)

Intercellular Signaling in Cardiovascular Development and Disease Laboratory, Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.
Ciber de Enfermedades Cardiovasculares, Instituto de Salud Carlos III, Madrid, Spain.

Jean-Pierre Desvignes (JP)

Aix Marseille University, Marseille Medical Genetics, INSERM U1251, Marseille, France.

Leticia Fernandez-Friera (L)

Ciber de Enfermedades Cardiovasculares, Instituto de Salud Carlos III, Madrid, Spain.
Translational Laboratory for Cardiovascular Imaging and Therapy, Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.
HM Hospitales-Centro Integral de Enfermedades Cardiovasculares, Madrid, Spain.

Manuel José Gomez (MJ)

Bioinformatics Unit, Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.

Eduardo Gil Vilariño (E)

Genomics Unit, Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.

Sergio Callejas Alejano (S)

Genomics Unit, Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.

Pablo Garcia-Pavia (P)

Ciber de Enfermedades Cardiovasculares, Instituto de Salud Carlos III, Madrid, Spain.
Departmento de Cardiología, Hospital Universitario Puerta de Hierro, Madrid, Spain.
Universidad Francisco de Vitoria, Pozuelo de Alarcón, Madrid, Spain.

Jorge Solis (J)

Departmento of Cardiología, Hospital Universitario Doce de Octubre, Madrid, Spain.

Joaquín Lucena (J)

Servicio de Patología Forense, Instituto de Medicina Legal y Ciencias Forenses.

David Salgado (D)

Aix Marseille University, Marseille Medical Genetics, INSERM U1251, Marseille, France.

Gwenaelle Collod-Béroud (G)

Aix Marseille University, Marseille Medical Genetics, INSERM U1251, Marseille, France.

Emilie Faure (E)

Aix Marseille University, Marseille Medical Genetics, INSERM U1251, Marseille, France.

Alexis Théron (A)

Service de Cardiologie, Hôpital de la Timone, Marseille, France.

Julia Torrents (J)

Service d'anatomie et Cytologie Pathologiques, Hôpital de la Timone, Marseille, France.

Jean-François Avierinos (JF)

Aix Marseille University, Marseille Medical Genetics, INSERM U1251, Marseille, France.
Service de Cardiologie, Hôpital de la Timone, Marseille, France.

Lorena Montes (L)

Hospital Clínico San Carlos, Madrid, Spain.

Ana Dopazo (A)

Genomics Unit, Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.

Valentín Fuster (V)

Cardiovascular Imaging and Population Studies Laboratory, Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.
Cardiology Department, Icahn School of Medicine at Mount Sinai, New York, New York.

Borja Ibañez (B)

Ciber de Enfermedades Cardiovasculares, Instituto de Salud Carlos III, Madrid, Spain.
Service d'anatomie et Cytologie Pathologiques, Hôpital de la Timone, Marseille, France.
Hospital Clínico San Carlos, Madrid, Spain.
IIS-Fundación Jiménez Díaz Hospital Universitario, Madrid, Spain.

Fátima Sánchez-Cabo (F)

Bioinformatics Unit, Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.

Stephane Zaffran (S)

Aix Marseille University, Marseille Medical Genetics, INSERM U1251, Marseille, France.

José Luis de la Pompa (JL)

Intercellular Signaling in Cardiovascular Development and Disease Laboratory, Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.
Ciber de Enfermedades Cardiovasculares, Instituto de Salud Carlos III, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH